vimarsana.com
Home
Live Updates
GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update : comparemela.com
GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update
Phase 2 clinical trial of temelimab against neuropsychiatric syndromes of Post-COVID :
Recruitment completed in November 2023;
Topline results planned for end of June 2024.
Cash position...
Related Keywords
United States ,
France ,
Switzerland ,
Geneva ,
Genè ,
Swiss ,
French ,
,
Research Tax Credit ,
European Investment Bank ,
Research Development ,
Swiss Federal Office Of Public Health ,
French Research Tax Credit ,
European Union ,
Regulatory News ,
Euronext Paris ,
Swiss Federal Office ,
Public Health ,
Lateral Sclerosis ,
Statutory Auditors ,
Geneuro Innovation ,
Tax Credit ,
Markets ,
comparemela.com © 2020. All Rights Reserved.